Filed in archive
Corporate and Industrial News
, Genomics, Proteomics and Bioinformatics
by ruth on September 29, 2005

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. Genomic Health's Oncotype DX� breast cancer Assay is alrady available for use to quantify the likelihood of breast cancer recurrence and predict benefit with certain types of chemotherapy for an individual patient.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/9844
Mr Wong
Vote for Genomic Health, Inc. Announces Pricing of Initial Public Offering:
|
Rating: 10.00 out of 1 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







